Cargando…
Genetic Profiling in Diffuse Large B Cell Lymphoma – the promise and the challenge
Diffuse Large B Cell lymphoma (DLBCL) is the commonest non-Hodgkin lymphoma. Over the last two decades tremendous progress has been made in our understanding of the molecular pathogenesis of DLBCL. However, this biological understanding has not yet been translated into improved first-line therapy. A...
Autores principales: | Cutmore, Natasha H., Krupka, Joanna A., Hodson, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614242/ https://www.ncbi.nlm.nih.gov/pubmed/36788062 http://dx.doi.org/10.1016/j.modpat.2022.100007 |
Ejemplares similares
-
Angiomirs expression profiling in diffuse large B-Cell lymphoma
por: Borges, Natália M., et al.
Publicado: (2015) -
Genetic and epigenetic determinants of diffuse large B-cell lymphoma
por: Bakhshi, Tanner J., et al.
Publicado: (2020) -
A Promising Future for Precision Epigenetic Therapy for Follicular and Diffuse Large B-Cell Lymphoma?
por: Chung, Clement
Publicado: (2022) -
Acquired CARD11 Mutation Promotes BCR Independence in Diffuse Large B Cell Lymphoma
por: Caeser, Rebecca, et al.
Publicado: (2021) -
Mutational profile of primary breast diffuse large B-cell lymphoma
por: Franco, Fernando, et al.
Publicado: (2017)